Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed And Cisplatin in Patients With ASS1-Deficient Mesothelioma: Safety, Efficacy and Resistance Mechanisms

Authors
Publication date
3 September 2020
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Supporting member

      Queen Mary Research Online

      redirect
      oaioai:qmro.qmul.ac.uk:123456789/...
      Last time updated on 11/12/2020